Russian President Vladimir Putin underwent revaccination against coronavirus with a nasal form of vaccine at the N.N. N.F. Gamalei. He announced this at a meeting with members of the government. The broadcast was carried out on the TV channel “Russia 24”.
“Exactly six months after the vaccination, my protective titers dropped, and the experts recommended a revaccination procedure, which I did a few days ago. At first he did it in the form of an injection, and the next day, after a conversation with Denis Yuryevich (Logunov, deputy director of the N.F. , namely, this nasal powder, “- said Putin.
According to the president, the vaccine is injected with an ordinary syringe, but instead of a liquid vaccine, it is filled with powder. After this vaccination, Putin sat for 15 minutes. “And that’s it. To be honest, I didn’t have any feelings, just nothing, ”Putin added. The president went in for sports today. “I can testify that everything is developing the way our scientists and specialists say,” he said. The President recommended getting vaccinated and boosted on time to protect against coronavirus.
The President recommended getting vaccinated and boosted on time to protect against coronavirus. He also noted that vaccination against coronavirus should be voluntary: you should not impose vaccination on people, but convince them to get vaccinated.
On November 21, during a meeting with Denis Logunov, Putin announced that he had been revaccinated with the Sputnik Light vaccine. He did the primary vaccination with Sputnik V. During the meeting, Putin said that he would like to participate in trials of the nasal form of the coronavirus vaccine.
Two nasal forms of a coronavirus vaccine based on Sputnik V may appear in Russia – they are being developed by the Gamaleya Center and the Generium company, which bought the license for such development. The general director of Generium, Daniil Talyansky, said that this form of the drug is tolerated softer than the classical one, but is not inferior in effectiveness. The company is awaiting permission from the Ministry of Health to conduct clinical trials.
In an interview with Rossiyskaya Gazeta, Gunzburg explained that the nasal vaccine creates immunity to coronavirus in the nasopharynx, and Sputnik V – in the blood, so the drugs should complement each other and create two protective barriers. Gunzburg later reported that the developers did not register any side effects from the nasal vaccine.